Risk of acute coronary syndrome in patients with cervical spondylosis

Cervical spondylosis (CS) is reported to be associated with increased sympathetic activity and hypertension. However, the cardiovascular (CV) outcomes of patients with CS are largely unknown. A national insurance claims dataset of 22 million enrollees in Taiwan during 1999–2010 was used as the research database. We identified 27,948 patients with CS and age-, sex-, and comorbidity-matched controls. By using multivariate logistic regression analysis after adjustment for potential cardiovascular (CV) confounders, we calculated odds ratios (ORs) with 95% confidence intervals (CIs) to quantify the association between CS and acute coronary syndrome (ACS). A total of 744 ACS events were identified among the 27,948 patients with CS. The overall incidence of ACS was 4.27 per 1000 person-years in the CS cohort and 3.90 per 1000 person-years in the non-CS cohort, with an adjusted hazard ratio (aHR) of 1.13 (95% CI = 1.08–1.18). The aHRs of ACS were 1.08 (95% CI = 1.03–1.15) in the CS cohort without myelopathy and 1.20 (95% CI = 1.13–1.28) in the CS cohort with myelopathy, compared with the non-CS cohort. Compared with patients with CS without neurological signs, patients with CS receiving rehabilitation exhibited a 0.67 aHRs of ACS (95% CI = 0.59–0.76), whereas those with neurological signs receiving spinal decompression exhibited 0.73 aHRs of ACS (95% CI = 0.63–0.84). CS is associated with an increased risk of ACS. Receiving treatment for CS, either rehabilitation or spinal decompression, is associated with less risk of ACS. •Cervical spondylosis (CS) is associated with an increased risk of acute coronary syndrome (ACS).•Receiving treatment for CS, either rehabilitation or spinal decompression, reduces the risk of ACS.•CS patients who had recognized CV risk factors including hypertension, hyperlipidemia, diabetes, renal disease, lung disease, and previous stroke had increasing incidence of ACS.